Clinical Trials Directory

Trials / Completed

CompletedNCT04872868

Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis

Evaluation of the Long-term Effect of a 3-month Supplementation With Holo-BLG (Food for Special Medical Purposes) in People With Allergic Rhinoconjunctivitis Caused by House Dust Mites During Inhalation Exposure to Mite Allergen in an Exposure Chamber.

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Ecarf Institute GmbH · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the long-term effect of a lozenge containing beta-lactoglobulin (BLG), iron, retinoic acid, zinc and polyphenols (holo-BLG) in people with allergic rhinoconjunctivitis caused by house dust mites and the associated symptoms (symptom type and severity) during exposure to house dust mites in an Allergen Exposure Chamber (AEC). In particular, the study aims to evaluate whether the improvements in symptoms of house dust mite-induced rhinoconjunctivitis observed after 3 months of supplementation with holo-BLG can still be detected 7 to 8 months after the last intake.

Conditions

Timeline

Start date
2021-01-27
Primary completion
2021-02-12
Completion
2021-02-12
First posted
2021-05-05
Last updated
2022-04-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04872868. Inclusion in this directory is not an endorsement.

Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis (NCT04872868) · Clinical Trials Directory